Aim To determine preferable type of treatment in our clinical circumstances by following two groups of patients with critical limb ischemia (CLI), who were treated endovascularly and surgically. Methods Research was carried out in the form of a prospective study of 80 patients with CLI and TransAtlantic Inter-Society Consensus (TASC) C or D type of arterial disease, with American Society of Anesthesiology (ASA) class III risk, who were randomly divided in two groups as per the treatment they received, surgical and endovascular. Patients were followed during 28 months using clinical examination and Duplex Ultrasound (DUS) in accordance with prescheduled control visits. Results There was a statistical difference between surgical and endovascular group in two years patency (82.5% vs. 55%; p=0.022) but it did not result in the difference in amputation free survival (AFS) (95% vs. 85%; p=0.171) or two-year freedom from major adverse limb events (MALE) (87.5 vs. 77.5; p=0.254). Also, there was no difference in the overall survival of patients (100% vs. 97.5%; p=0.317). Conclusion Initial endovascular treatment is a preferred form of the treatment for selected patient population.
Bradbury A, Adam D, Bell J, Forbes J, Fowkes F, Gillespie I, et al. Bypass Versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial. An intention-totreat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplasty-first revascularization strategy. J VascSurg. 2010. p. 5S – 17.
2.
Goodney P, Schanzera, Demartino R, Nolan D, Nathanael D, Hevelone N. Validation of the Society for vascular surgery’s Objective Performance Goals (OPGs) for critical limb ischemia in everyday vascular surgery practice. J Vasc Surg. 2011. p. 100–8.
3.
Conte M, Geraghty P, Bradbury A. Suggested objective performance goals and clinical trial design for evaluating catheter-based treatment of critical limb ischemia. J Vasc Surg. 2009. p. 1462–73.
4.
Norgren L, Hiatt W, Dormandy J. TASC II Working Group: Inter-Society Consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg. 2007. p. 29–30.
5.
Losa S, Ruscazio A, Faglia E, Mantero M, Gabrielli L. Endovascular and surgical treatment of chronic limb ischaemia in diabetics. Ital J VascEndovasc Surg. 2014. p. 351–9.
6.
Belvins W, Schneider P. Endovascular management of critical limb ischemia. Eur J VascEndovasc Surg. 2010. p. 756–61.
7.
Masaki H, Tabuchi A, Yunokiy, Watanabe Y, Mimura D, Furukawa H. Bypass vs. endovascular therapy of infrapopliteal lesions for critical limb ischemia. Ann Vasc Dis. 2014. p. 227–31.
8.
Dosluoglu H, Lall P, Harris L, Dryjski M. Long-term limb salvage and survival after endovascular and open revascularization for critical limb ischemia after adoption of endovascular-first approach by vascular surgeons. J Vasc Surg. 2012. p. 361–71.
9.
Söderström M, Arvela E, Korhonen M, Halmesmäki K, Albäck A, Biancari F, et al. Infrapopliteal percutaneous transluminal angioplasty versus bypass surgery as first-line strategies in critical leg ischemia: a propensity score analysis. Ann Surg. 2010. p. 765–73.
10.
Dosluoglu H, Lall P, Blochle R, Harris L, Dryjski M. Clinical presentation and outcome after failed infrainguinal endovascular and open revascularization in patients with chronic limb ischemia. Vasc Surg. 2013. p. 98–104.
11.
Sandford R, Bown M, Sazers R, London J, Nazlor A, Mccarthy M. Is infrainguinal bypass grafting successful following failed angioplasty? Eur J Vasc Endovasc Surg. 2007. p. 29–34.
12.
Santo V, Dargon P, Azarbal A, Liem T, Mitchell E, Landry G, et al. Lower extremity autologous vein bypass for critical limb ischemia is not adversely affected by prior endovascular procedure. J Vasc Surg. 2014. p. 129–35.
13.
Dabrh A, Steffen A, Asi M, Undavalli N, Wang C, Elamin Z, et al. Bypass surgery versus endovascular interventions in severe or critical limb ischemia. J Vasc Surg. 2016. p. 244–53.
14.
Beard J. Which is the best revascularization for critical limb ischemia: Endovascular or open surgery? J Vasc Surg. 2008. p. 11S – 16.
15.
Korhonen M, Biancari F, Soderstrom M, Arvelae, Halmesmakik A. Femoropopliteal balloon angioplasty vs. bypass surgery for CLI: a propensity score analysis. Eur J Vasc Endovasc Surg. 2011. p. 378–84.
16.
Sidi A, Lobato E, Cohen J. The American Society of Anesthesiologists’ Physical Status: category V revisited. J Cli Anesth. 2000. p. 328–34.
17.
Jaff M, White C, Hiatt W, Fowkes G, Dormandy J, Razavi M, et al. An update on methods for revascularization and expansion of the TASC lesion classification to include belowthe-knee arteries: A supplement to the inter-society consensus for the management of peripheral arterial disease (TASC II): The TASC Steering Committee. Ann Vasc Dis. 2015. p. 343–57.
18.
Lejey A, Schaeffer M, Georg Y, Lucereau B, Roussin M, Girsowicz E. Gender related long-term differences after open infrainguinal surgery for critical limb ischemia. Eu J Vasc Endovasc Surg. 2015. p. 506–12.
19.
Jackson E, Munir K, Schreiber T, Rubin J, Cuff R, Gallagher K, et al. Impact of sex on morbidity and mortality rates after lower extremity interventions for peripheral arterial disease: observations from the Blue Cross Blue Shield of Michigan cardiovascular consortium. J Am Coll Cardiol. 2014. p. 2525–30.
20.
Meltzer A, Graham A, Connolly P, Meltzer E, Karwowski J, Bush H, et al. The comprehensive risk assessment for bypass (CRAB) facilitates efficient perioperative risk assessment for patients with critical limb ischemia. J Vasc Surg. 2013. p. 1186–95.
21.
Patel M, Conte M, Cutlip D, Dib N, Geraghty P, Gray W. Evaluation and treatment of patients with lower extremity peripheral artery disease: consensus definitions from Peripheral Academic Research Consortium (PARC). J Am Coll Cardiol. 2015. p. 931–41.
22.
Simson E, Kearns B, Stevenson M, Cantrell A, Littelwood C, Michaels J. Enhancement to angioplasty for peripheral arterial disease: systematic review, cost-effectiveness assessment and expected value of information analysis. Health Technol Assess. 2014. p. 1–252.
23.
Zimmermann A, Ludwig U, Eckstein H. Indications and results of endovascular therapy of critical limb ischemia. Radiologe. 2016. p. 543–9.
24.
Nordanstig J, Smidfelt K, Langenskiöld M. Kragsterman B. Nationwide experience of cardio and cerebrovascular complications during infrainguinal endovascular intervention for peripheral arterial disease and acute limb ischaemia. Eur J Vasc Endovasc Surg. 2013. p. 270–4.
25.
Banerjee S, Pershwitz G, Sarode K, Mohammad A, Abu-Fadel M, Baigms. Stent and non-stent based outcomes of infrainguinal peripheral artery interventions from the multicenter XLPAD Registry. J Invasive Cardiol. 2015. p. 14–8.
26.
Forster R, Liew A, Bhattacharya V, Shaw J, Stansby G. Gene therapy for peripheral arterial disease. Cochrane Database Syst Rev. 2018. p. 31.
27.
Tsigkou V, Siasos G, Rovos K, Tripyla N. Tousoulis D. Peripheral artery disease and antiplatelet treatment. Curr Opin Pharmacol. 2018. p. 43–52.
28.
Lawall H, Huppert P, Espinola-Klein C, Silke-Zemmrich C, Ruemenapf G. German guideline on the diagnosis and treatment of peripheral artery disease -a comprehensive update. Vasa. 2016. p. 79–86.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
,
